Who is getting weight loss jags on the NHS in Scotland?

• NHS Scotland has approved weight loss medications (GLP-1 agonists) for three years, but uptake remains extremely low with fewer than 800 patients treated, suggesting significant implementation barriers requiring urgent review.
• The discrepancy between approval and prescribing indicates potential issues with commissioning, clinical pathways, or resource allocation that should be audited to understand why availability differs from policy intent.
• Clinicians should clarify local eligibility criteria and referral pathways for weight loss medications with their NHS boards, as access appears inconsistent across Scotland and may not reflect national approval status.

Fewer than 800 Scots have received jabs for weight loss on the NHS despite them being approved for use three years ago, BBC News has found.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.